MediClin AG is a Germany-based company. The Company is engaged in providing professional medical servies in the fields of acute care (acute segment) and rehabilitation (post-acute segment), as well as nursing care services, through its hospitals. It focuses on a range of services in the acture and post-acute segments, such as: neurology, neurological early rehabilitation, neurosurgery, psychosomatics and psychiatry, geriatrics, as well as orthopaedics. Other areas of special competencies are: tinnitus, cochlea implants and internal medicine (cardiology, pneumology, edocrinology), as well as the treatment of post- and long-COVID-19 symptoms.

Employees

7,416

Sector

Healthcare Facilities & Services

Calendar

07-30 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
17/07/26	€4.160	0.00%	100
16/07/26	€4.160	+0.97%	2,195
15/07/26	€4.120	+0.49%	4,732
14/07/26	€4.100	+0.49%	902
13/07/26	€4.080	+0.99%	2,865

Delayed Quote Xetra

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.160EUR

Average target price

7.300EUR

Spread / Average Target

+75.48%

Consensus

Net sales - Rate of surprise

Company calendar

Market Closed - Xetra Other stock markets 16:35:19 17/07/2026 BST			5-day change	1st Jan Change
4.160 ^EUR	0.00%		+2.97%	+12.43%

05-05	MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026	CI

Market Cap	198M 226M 182M 168M 317M 21.78B 324M 2.18B 857M 10.66B 849M 831M 36.71B	P/E 2026 *	-	P/E 2027 *	-
Enterprise Value	198M 226M 182M 168M 317M 21.78B 324M 2.18B 857M 10.66B 849M 831M 36.71B	EV / Sales 2026 *	0.25x	EV / Sales 2027 *	0.25x
Free-Float	12.27%	Yield 2026 *	0.96%	Yield 2027 *	0.96%

05-05	MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-04	MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026	CI
04-14	MEDICLIN Aktiengesellschaft announces Annual dividend, payable on June 02, 2026	CI
03-27	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Mediclin Aktiengesellschaft Provides Earnings Guidance for 2026	CI
11-05	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
01/08/25	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
31/07/25	MEDICLIN Aktiengesellschaft Provides Consolidated Earnings Guidance for the Full Year 2025	CI
02/05/25	MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
23/04/25	MEDICLIN Aktiengesellschaft announces Annual dividend, payable on June 10, 2025	CI
28/03/25	MEDICLIN Aktiengesellschaft Provides Group Earnings Guidance for 2025	CI
28/03/25	MEDICLIN Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2024	CI
21/01/25	MEDICLIN Aktiengesellschaft Raises Earnings Guidance for the Year 2024	CI

07-09	RPT: MEDICLIN AG: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution	EQ
05-29	MEDICLIN AG: Annual General Meeting approves all proposed resolutions	EQ
05-04	MEDICLIN increases group operating result in the first quarter	EQ
05-04	MEDICLIN : Interim report of MEDICLIN Aktiengesellschaft for the period from 1 January 2026 to 31 March 2026 PDF-File (338 KB) (Mediclin Q1 2026 E s)	PU
03-27	MEDICLIN : Annual Report 2025 - MEDICLIN Aktiengesellschaft PDF-File (6 MB) (MEDICLIN Annual Report 2025)	PU

MEDICLIN AG Share Price

Stocks

MED

DE0006595101

Healthcare Facilities & Services

Valuation: MEDICLIN AG

Chart: MEDICLIN AG

Latest news : MEDICLIN AG

Press Releases: MEDICLIN AG

News in other languages: MEDICLIN AG

Quotes and Performance

Course Extremes

Managers and Directors: MEDICLIN AG

Hospitals, Clinics & Primary Care Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Net sales - Rate of surprise

07-14	Neues Versorgungsangebot für die Region: MEDICLIN Müritz-Klinikum eröffnet noch dieses Jahr geriatrische Rehabilitation
07-10	MEDICLIN : 50 Jahre MEDICLIN Staufenburg Klinik – Ein halbes Jahrhundert Rehabilitation mit Herz und Fachkompetenz
07-09	RPT: MEDICLIN AG: Veröffentlichung gemäß § 111c AktG mit dem Ziel der europaweiten Verbreitung
07-06	MEDICLIN AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
07-03	40 Jahre MEDICLIN Klinikum Soltau: Festakt würdigt Erfolgsgeschichte und richtet Blick in die Zukunft

1 week	+2.97%
Current month	+5.05%
1 month	+2.46%
3 months	+20.93%
6 months	+4.52%
Current year	+12.43%

1 week	4.04	4.2
1 month	3.9	4.2
Current year	3.22	4.26
1 year	2.86	4.26
3 years	2.28	4.26
5 years	2.28	4.26
10 years	2.28	6.88

Manager	Title	Age	Since
Tino Marco Fritz CEO	Chief Executive Officer	49	-
Martin Buse CMP	Compliance Officer	-	-
Thomas Piefke COO	Chief Operating Officer	-	30/09/2023

Director	Title	Age	Since
Hans Hilpert BRD	Director/Board Member	60	31/12/2002
Michael Bock BRD	Director/Board Member	63	24/05/2005
Walburga Erichsmeier BRD	Director/Board Member	63	19/09/2012

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEDICLIN AG	0.00%	+2.97%	+41.50%	+37.75%	226M
IHH HEALTHCARE	-0.35%	+0.71%	+29.38%	+45.55%	18.34B
APOLLO HOSPITALS ENTERPRISE LIMITED	-0.70%	-0.17%	+20.85%	+70.96%	13.18B
AIER EYE HOSPITAL GROUP CO., LTD.	-3.66%	+3.95%	-30.62%	-54.55%	11.87B
ENCOMPASS HEALTH CORPORATION	-0.25%	+1.86%	+2.00%	+66.41%	11.13B
THE ENSIGN GROUP, INC.	-0.93%	+1.60%	+25.20%	+90.82%	9.93B
BANGKOK DUSIT MEDICAL SERVICES	+0.51%	+0.51%	-7.94%	-31.48%	9.31B
FORTIS HEALTHCARE LIMITED	-1.11%	-1.61%	+19.28%	+191.67%	7.47B
RAMSAY HEALTH CARE LIMITED	+1.13%	+2.79%	+11.02%	-23.94%	6.92B
PURE HEALTH HOLDING	-0.89%	-2.19%	-26.40%	-	6.75B
Average	-0.62%	+1.27%	+8.43%	+43.69%	9.51B
Weighted average by Cap.	-0.77%	+1.23%	+7.36%	+42.38%

	2026 *	2027 *
Net sales	787M 901M 727M 670M 1.26B 86.78B 1.29B 8.69B 3.42B 42.5B 3.38B 3.31B 146B	803M 919M 741M 683M 1.29B 88.51B 1.32B 8.86B 3.48B 43.35B 3.45B 3.38B 149B
Net income	36.66M 41.95M 33.83M 31.18M 58.78M 4.04B 60.08M 404M 159M 1.98B 158M 154M 6.81B	38.2M 43.71M 35.25M 32.49M 61.23M 4.21B 62.59M 421M 166M 2.06B 164M 161M 7.1B
Net Debt	-	-